IL2 and cancer: Another type of cancer immunotherapy is active immunotherapy, which involves administration of agents, such as interferons, interleukins (e.g., IL-2, IL15, and IL-12), vaccines, and genetically engineered T cells, to direct the immune system into taking an active role in attacking the cancer cells.